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165 An immunomodulatory role for the serine protease inhibitor,
eppin, in the lung
A. Glasgow1, A. Scott1, M. McCrudden1, D. McLean1, F. Lundy1, C. Irwin2,
D. Timson3, M. Tunney4, J.S. Elborn1, S. Weldon1, C. Taggart1. 1Queen’s
University Belfast, Centre for Infection and Immunity, Belfast, United Kingdom;
2Queen’s University Belfast, Centre for Dental Education, Belfast, United
Kingdom; 3Queen’s University Belfast, School of Biological Sciences, Belfast,
United Kingdom; 4Queen’s University Belfast, School of Pharmacy, Belfast, United
Kingdom
Objectives: Small molecular weight proteins involved in innate host defence, for
example SLPI, have demonstrated some efﬁcacy in clinical CF trials as a way of
controlling inﬂammation. We investigated the immunomodulatory and anti-bacterial
activity of a related protein, eppin, in vitro.
Methods: THP-1 monocytes and monocyte-derived macrophages were given LPS
alone or pre-incubated with recombinant eppin prior to LPS activation. Expression
and secretion of cytokines were measured by RT-PCR and ELISA respectively.
Nuclear extracts were prepared and p65 activity compared using a TransAm activity
ELISA. Binding of eppin to the consensus NF-úB binding site was evaluated
by EMSA. IúBa, phosphorylated IúBa and polyubiquitinated protein levels in
cytoplasmic lysates were assessed by Western blot. Membrane permeabilisation
assays were used to test the bactericidal effects of eppin. CF sputum samples were
screened for endogenous eppin via Western blotting.
Conclusion: THP-1 monocytes and macrophages showed impaired cytokine ex-
pression and secretion if given recombinant eppin before LPS stimulation. Further
investigation showed that NF-úB activity was signiﬁcantly reduced in cells pre-
treated with eppin, but eppin did not appear to bind the NF-úB consensus site.
Levels of phosphorylated IúBa and total ubiquitinated protein were increased in
cells pre-incubated with eppin prior to LPS. Recombinant eppin permeabilised the
membranes of lung-relevant bacteria. Endogenous eppin was detected in CF sputa.
The results from this study point towards a role for eppin in the innate immune
response in the lung and it could therefore prove valuable as a therapeutic option
in CF.
166 Beneﬁcial immunomodulatory effect of vardenaﬁl in mouse CF
macrophages
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Objectives: We previously showed that F508del-CFTR homozygous mice display
increased numbers of alveolar and peritoneal macrophages. We also demonstrated
that Vardenaﬁl, a phosphodiesterase type 5 inhibitor, reduces LPS-induced inﬂam-
matory responses in CF mice. We hypothesized that the activity of macrophages
is altered in CF and that macrophages represent target effectors of the anti-
inﬂammatory effect of vardenaﬁl.
Methods: Macrophages from lung homogenates and peritoneal lavages were iso-
lated from CF and WT mice. To determine if the activity of macrophages is altered
in CF, LPS-induced inﬂammatory responses were ﬁrst evaluated. Then, macrophage
differentiation in pro/anti-inﬂammatory effectors was studied using a M1 (LPS and
IFN-g) or M2 (IL-4 and IL-13) polarization protocol. Pro- (TNF-a, IL-1b and
CCL-2) and anti-inﬂammatory (FIZZ-1 and mYm1) mediators were quantiﬁed by
ELISA (supernatants) or qRT-PCR (macrophages). In each condition, the effect of
vardenaﬁl (50mM) was tested.
Conclusion: CF macrophages displayed an exaggerated pro-inﬂammatory response
to LPS. M1/M2 polarization was altered in CF macrophages. M1 responses were
at least 4-fold larger and M2 responses were reduced in CF compared to WT cells,
which conﬁrms the pro/anti-inﬂammatory unbalance in CF macrophages. Vardenaﬁl
reduces the expression of TNF-a and IL-1b and corrects FIZZ-1 overproduction in
CF macrophages. These results suggest that the differentiation of macrophages
from different body compartments is oriented towards both an increased pro-
inﬂammatory and a decreased anti-inﬂammatory status. The immunomodulatory
effect of vardenaﬁl could be beneﬁcial in CF pharmacotherapy.
167 Molecular mechanisms of enhanced expression of interleukin 8
(CXCL8) in cystic ﬁbrosis (CF) airway epithelial (AE) cells
A. Poghosyan1, R.L. Clifford1, W. Coward1, L. Pang1, A.J. Knox1. 1University of
Nottingham, Division of Respiratory Medicine, Nottingham, United Kingdom
Objectives: The Aim of this study was to investigate the transcriptional mechanisms
of CXCL8 production basally and following induction by IL-1b in immortalized
CFTR-deﬁcient AE (CFTR-AE) cells and their corrected counterparts.
Methods: CXCL8 secretion/expression was measured by ELISA/RT-PCR respec-
tively. Transcriptional regulation was assessed by transient transfection of wild type
(WT) CXCL8 promoter constructs. The involvement of individual transcription
factors was assessed using CXCL8 promoter luciferase constructs with mutated
binding sites for NF-úB, AP-1, and C/EBPb. Chromatin immunoprecipitation
(ChIP) measured binding of transcription factors to the CXCL8 promoter.
Conclusion: CFTR-AE cells secreted higher levels of CXCL8 compared to their
corrected counterparts both basally and after stimulation with IL-1b. CFTR-AE
cells expressed increased levels of CXCL8 transcript and exhibited increased WT
CXCL8 promoter luciferase activity. Mutation of NF-úB, AP-1 and C/EBPb binding
sites abolished CXCL8 promoter luciferase activity suggesting that all 3 factors are
required for CXCL8 expression. ChIP assay showed increased C/EBPb binding
to the CXCL8 promoter in CFTR-AE cells. These studies suggest that CFTR-AE
cells produce increased levels of CXCL8 due to higher binding of C/EBPb to the
CXCL8 promoter. Current studies focus on determining the underlying epigenetic
mechanisms responsible for increased transcription factors binding.
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Objectives: Pseudomonas aeruginosa is one of the most common bacteria found in
sputum from people with Cystic Fibrosis (CF). The bacteria can grow in aerobic and
anaerobic environments resulting in an immune response in the host involving the
release of inﬂammatory cytokines and proteolytic enzymes. Cycles of persistent
infection and inﬂammatory response leads to lung injury and decreased lung
function. This study investigates whether P. aeruginosa cultured under aerobic and
anaerobic conditions induce a similar inﬂammatory response in CF airway epithelial
cells.
Methods: Aerobic and anaerobic lysates or heat inactivated P. aeruginosa type
strains (PA01 & PA14) and clinical isolates (B003, B008, B021) were co-incubated
with CFBE cells for 2 hours, 6 hours and 24 hours. The pro-inﬂammatory signalling
molecules IL-6, IL-8 and G-CSF were measured in the cell-conditioned media by
ELISA, whilst the activity from the remodelling lung degrading proteases, Cathepsin
B and Cathepsin S were measured by kinetic ﬂuorogenic assay.
Results:When compared to unstimulated control cells, the heat inactivated bacteria
induced the greatest secretion of IL-8 (435%) and IL-6 (922%). However, G-CSF
levels (1306%) and Cathepsin B (19889%) and S (390%) activity were highest
following stimulation by bacterial lysates. In 3 of the biomarkers (Cat B, IL-8 and
IL-6) the anaerobic bacteria induced a greater response in comparison to the aerobic
bacteria.
Conclusion: The data demonstrates variability in inﬂammatory response from
CFBE cells. However in the majority of biomarkers the anaerobic bacteria invoke
a greater inﬂammatory response.
